Viral Vector– tag –
-
OXB Accelerates Gene Therapy Production for Plowshare Therapies, Leveraging FDA-Approved AAV Manufacturing in North Carolina
Markets Insider UK Overview OXB has partnered with Plowshare Therapies to provide crucial process development and GMP manufacturing for Plowshare’s AAV gene therapy program. This collaboration leverages OXB's FDA-approved commercial-scal... -
Fujifilm Diosynth Commits $2 Billion to North Carolina Gene Therapy Facility Amid Supply Chain Shifts; India Emerges as Key CDMO Hub
BioSpace Global Overview Fujifilm Diosynth is investing approximately $2 billion in a new gene therapy manufacturing facility in North Carolina, strategically positioning against global supply chain shifts. Catalent, under Novo Holdings,... -
Crystalys Therapeutics Secures $35M Series A Funding to Advance Gene Therapy Development
BioBucks USA Overview Crystalys Therapeutics, a gene therapy developer, has raised $35 million in a Series A funding round. This capital will accelerate the research and development of its innovative gene therapy pipeline, targeting unme... -
UC Berkeley’s Doudna Lab Redesigns Minimal CRISPR Nucleases with AI, Revolutionizing In Vivo Delivery
CRISPR Medicine News USA Overview Researchers at UC Berkeley's Innovative Genomics Institute (IGI), including Jennifer Doudna, have published a Science paper detailing an AI-powered technique to minimize and redesign CRISPR nucleases. Th... -
Regeneron to Seek Approval for Hearing Loss Gene Therapy Following “Game-Changing” Clinical Data
BioPharma Dive USA Overview Regeneron plans to seek regulatory approval for its gene therapy for rare genetic hearing loss, based on "game-changing" clinical trial data published in the New England Journal of Medicine. The therapy demons... -
FUJIFILM Cellular Dynamics Opens iPSC Manufacturing Facility, Made Scientific & Pluristyx Announce iPSC Partnership Expansion
openPR.com USA Overview According to openPR.com, FUJIFILM Cellular Dynamics opened a new iPSC development and manufacturing facility in Madison in May 2026, significantly expanding its induced pluripotent stem cell production capacity. F... -
Green Elephant Biotech Highlights 74% Cost Reduction Potential and Accelerated Development in Cell & Gene Therapy Through Automation
Green Elephant Biotech Germany Overview Green Elephant Biotech has highlighted the potential of automation platforms to significantly reduce development timelines and manufacturing costs in cell and gene therapy (CGT). Cases like Multipl... -
NIH’s NCATS Secures FDA IND Clearance for Gene Therapy Targeting Ultra-Rare Multiple Sulfatase Deficiency
National Center for Advancing Translational Sciences - NIH USA Overview The National Center for Advancing Translational Sciences (NCATS), part of the NIH, announced FDA clearance of an Investigational New Drug (IND) application for a gen... -
uBriGene Launches uVivo Lentiviral Vector Platform to Accelerate Next-Generation In Vivo CAR T Therapies
Morningstar (Provided by ACCESS Newswire) Unknown Overview uBriGene has introduced its uVivo lentiviral vector platform, designed to significantly accelerate the development of next-generation in vivo CAR T-cell therapies. This platform ... -
NIH-Funded Team Discovers Miniaturized CRISPR Enzyme Al3Cas12f, Enabling Precision In Vivo Gene Delivery via AAV Vectors
National Institutes of Health (NIH) USA Overview An NIH-funded research team has discovered a novel, enhanced miniaturized CRISPR gene-editing system, a natural enzyme named 'Al3Cas12f,' capable of targeted in vivo delivery. This enzyme ...
